Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SmithKline Aquafresh Whitening parity/superiority claims to be clarified -- NARB ruling.

This article was originally published in The Rose Sheet

Executive Summary

SMITHKLINE AQUAFRESH WHITENING PARITY/SUPERIORITY CLAIMS TO BE CLARIFIED following a review by the National Advertising Review Board of SmithKline Beecham's television ads, according to a NARB Panel Report published Nov. 12. NARB concludes that the proximity of parity claims in ads comparing Aquafresh Whitening and Den-Mat's Rembrandt Whitening to Procter & Gamble's Crest results in an implied superiority claim of Aquafresh over Rembrandt. The claims in question that appeared in the ad are: "Not even Rembrandt can whiten better than Aquafresh Whitening"; "Even Rembrandt can't beat Aquafresh Whitening" and "In fact it's clinically proven to whiten better than Crest."

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004856

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel